Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2853 (LINC02853) is a human gene encoding a long non-coding RNA (lncRNA) that does not overlap protein-coding genes and is identified based on genome-wide transcriptomic data. LINC02853's molecular class is lincRNA: a type of RNA sequence longer than 200 nucleotides, not known to encode protein products. The biological functions, roles in disease, drug interactions, or therapeutic relevance for LINC02853 have not been characterized in current primary or secondary biomedical databases[1][5]. More broadly, lincRNAs are increasingly recognized for their potential regulatory roles in cell biology and disease, but functional assignment for LINC02853 is lacking.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2853 (LINC02853).